Aquestive Therapeutics Announces Successful Completion of Phase 1 Trial for AQST-108 (Sublingual Film Formulation Delivering Systemic Epinephrine)
Stock Information for Aquestive Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.